SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-002688
Filing Date
2015-05-08
Accepted
2015-05-08 15:16:03
Documents
14
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050815.htm 10-Q 943441
2 EXHIBIT 10.2 exh_102.htm EX-10.2 1743273
3 EXHIBIT 31.1 exh_311.htm EX-31.1 16652
4 EXHIBIT 31.2 exh_312.htm EX-31.2 18508
5 EXHIBIT 32.1 exh_321.htm EX-32.1 7141
6 EXHIBIT 32.2 exh_322.htm EX-32.2 6873
13 timephased.jpg GRAPHIC 134099
14 seal.jpg GRAPHIC 43038
  Complete submission text file 0001171843-15-002688.txt   8279251

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcrx-20150331.xml EX-101.INS 1091757
8 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20150331.xsd EX-101.SCH 45583
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20150331_cal.xml EX-101.CAL 26989
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20150331_def.xml EX-101.DEF 194349
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20150331_lab.xml EX-101.LAB 311698
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20150331_pre.xml EX-101.PRE 191769
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 15846291
SIC: 2836 Biological Products, (No Diagnostic Substances)